Skip to content
Home/Companies/Pharma/Purpose Pharma

Purpose Pharma

Pharma·Sweden·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns Purpose Pharma?

Purpose Pharma is currently owned by Eir Ventures through Eir Ventures I (2020 vintage), since 2024.

Hand-verified · updated 2026-08-17

Eir Ventures
Investor
Eir Ventures
Eir Ventures I · 2020 · Life Sciences VC

Key facts

HQSweden
SectorPharma
StatusActive

More from Eir Ventures I

Other portfolio companies in the same fund.

Moleculent
Active
BiotechSweden· 2024
Dania Tx
Active
BiotechDenmark· 2023
GutCRINE
Active
BiotechDenmark· 2023
RAPP
Active
HealthTechSweden· 2023
Scenic Biotech
Scenic Biotech
Active
BiotechNetherlands· 2023
Attgeno
Active
BiotechSweden· 2022

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Ceva
Ceva
Exited 2025
iXO Private EquityFrance
to
Laboratoires Delbert
Active
SocadifFrance
Pharmathen
Active
Partners GroupGreece
AMW
AMW
Active
SHS Gesellschaft für BeteiligungsmanagementGermany· 2026
Basic Pharma
Active
SHS Gesellschaft für BeteiligungsmanagementNetherlands· 2026
Biogaran
Biogaran
Active
Bpifrance InvestissementFrance· 2026
Track Purpose Pharma

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Purpose Pharma?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Purpose Pharma.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue